From the Department of Neurology (I.R.K., B.P.G.), Division of Neurocritical Care, and Department of Anesthesiology and Perioperative Medicine (Y.G.), University of Rochester Medical Center, NY; Department of Pathology (L.M., C.-Y.H.), University of Maryland Medical Center, Baltimore; Department of Pathology (K.S.C.), University of Michigan School of Medicine, Ann Arbor; Cardiac Surgery Research (F.F.), University of Maryland School of Medicine, Baltimore; College of Arts & Sciences (J.D., N.Q.), University of Rochester, NY; University of Maryland School of Medicine (A.R.); Program in Trauma and Critical Care (D.L.H.), Department of Medicine, and Program in Trauma (G.Y.P.), Division of Neurocritical Care and Emergency Neurology, Department of Neurology, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore; and Department of Pathology and Laboratory Medicine (M.D.J.), University of Rochester School of Medicine & Dentistry, NY.
Neurology. 2021 Mar 2;96(9):e1278-e1289. doi: 10.1212/WNL.0000000000011525. Epub 2021 Jan 20.
To test the hypothesis that brain injury is more common and varied in patients receiving extracorporeal membrane oxygenation (ECMO) than radiographically observed, we described neuropathology findings of ECMO decedents and associated clinical factors from 3 institutions.
We conducted a retrospective multicenter observational study of brain autopsies from adult ECMO recipients. Pathology findings were examined for correlation with demographics, clinical data, ECMO characteristics, and outcomes.
Forty-three decedents (n = 13 female, median age 47 years) received autopsies after undergoing ECMO for acute respiratory distress syndrome (n = 14), cardiogenic shock (n = 14), and cardiac arrest (n = 15). Median duration of ECMO was 140 hours, most decedents (n = 40) received anticoagulants; 60% (n = 26) underwent venoarterial ECMO, and 40% (n = 17) underwent venovenous ECMO. Neuropathology was found in 35 decedents (81%), including microhemorrhages (37%), macrohemorrhages (35%), infarctions (47%), and hypoxic-ischemic brain injury (n = 17, 40%). Most pathology occurred in frontal neocortices (n = 43 occurrences), basal ganglia (n = 33), and cerebellum (n = 26). Decedents with hemorrhage were older (median age 57 vs 38 years, = 0.01); those with hypoxic brain injury had higher Sequential Organ Failure Assessment scores (8.0 vs 2.0, = 0.04); and those with infarction had lower peak Paco (53 vs 61 mm Hg, = 0.04). Six of 9 patients with normal neuroimaging results were found to have pathology on autopsy. The majority underwent withdrawal of life-sustaining therapy (n = 32, 74%), and 2 of 8 patients with normal brain autopsy underwent withdrawal of life-sustaining therapy for suspected neurologic injury.
Neuropathological findings after ECMO are common, varied, and associated with various clinical factors. Further study on underlying mechanisms is warranted and may guide ECMO management.
为了验证脑损伤在接受体外膜肺氧合(ECMO)治疗的患者中比影像学观察到的更常见且更多样化的假设,我们描述了来自 3 家机构的 ECMO 死亡患者的神经病理学发现以及相关的临床因素。
我们对接受 ECMO 治疗的成人患者进行了回顾性多中心观察性研究。检查了病理学发现与人口统计学、临床数据、ECMO 特征和结果的相关性。
43 名死者(n = 13 名女性,中位年龄 47 岁)在接受急性呼吸窘迫综合征(n = 14)、心源性休克(n = 14)和心脏骤停(n = 15)的 ECMO 治疗后接受了尸检。ECMO 的中位时间为 140 小时,大多数死者(n = 40)接受了抗凝治疗;60%(n = 26)接受了静脉-动脉 ECMO,40%(n = 17)接受了静脉-静脉 ECMO。35 名死者(81%)发现了神经病理学变化,包括微出血(37%)、大出血(35%)、梗死(47%)和缺氧缺血性脑损伤(n = 17,40%)。大多数病理学改变发生在前额叶皮质(n = 43 处)、基底节(n = 33 处)和小脑(n = 26 处)。有出血的死者年龄更大(中位年龄 57 岁比 38 岁, = 0.01);有缺氧性脑损伤的死者序贯器官衰竭评估评分更高(8.0 分比 2.0 分, = 0.04);有梗死的死者峰值 Paco 更低(53 毫米汞柱比 61 毫米汞柱, = 0.04)。9 名神经影像学结果正常的患者中有 6 名在尸检中发现了病理学改变。大多数患者接受了生命支持治疗的撤除(n = 32,74%),8 名脑尸检正常的患者中有 2 名因疑似神经损伤而接受了生命支持治疗的撤除。
ECMO 后神经病理学发现很常见,且变化多样,并与各种临床因素相关。需要进一步研究潜在机制,这可能有助于指导 ECMO 管理。